Laboratorios Farmaceuticos Rovi
NDC Database

Laboratorios Farmaceuticos Rovi

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 4
  • Latest Marketing Date 2024-01-01
  • Data Source FDA
  • First Marketing Date 2021-06-01
Company Overview

Company

Laboratorios Farmaceuticos Rovi

Country

Spain

Website

Visit Website

Email

rovi@rovi.es

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Laboratorios Farmaceuticos Rovi

Calle José Isbert, 2 - 28223 Pozuelo de Alarcón (Madrid)

Spain

www.rovicm.es/index.php rovi@rovi.es View on Map
NDC Records ( 4 records )
2024
01 Jan
Drug for Further Processing NDC: 68263-223

Nonproprietary Name

Taurolidine, Heparin

Dosage Form

SOLUTION

Strength

3000; 40.5 [USP'U]/3mL; mg/3mL

Labeler

ROVI Pharma Industrial Services SA

Marketing Category

DRUG FOR FURTHER PROCESSING

68263-223

Substance

HEPARIN; TAUROLIDINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2024
01 Jan
Drug for Further Processing NDC: 68263-224

Nonproprietary Name

Taurolidine, Heparin

Dosage Form

SOLUTION

Strength

5000; 67.5 [USP'U]/5mL; mg/5mL

Labeler

ROVI Pharma Industrial Services SA

Marketing Category

DRUG FOR FURTHER PROCESSING

68263-224

Substance

HEPARIN; TAUROLIDINE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2024-01-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
01 Jun
Drug for Further Processing NDC: 68263-387

Nonproprietary Name

alendronate sodium and cholecalciferol

Dosage Form

TABLET

Strength

70; 2800 mg/30kg; [iU]/30kg

Labeler

ROVI Pharma Industrial Services SA

Marketing Category

DRUG FOR FURTHER PROCESSING

68263-387

Substance

ALENDRONATE SODIUM; CHOLECALCIFEROL

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-06-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
01 Jun
Drug for Further Processing NDC: 68263-674

Nonproprietary Name

alendronate sodium and cholecalciferol

Dosage Form

TABLET

Strength

70; 5600 mg/30kg; [iU]/30kg

Labeler

ROVI Pharma Industrial Services SA

Marketing Category

DRUG FOR FURTHER PROCESSING

68263-674

Substance

ALENDRONATE SODIUM; CHOLECALCIFEROL

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2021-06-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    2 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

68263-223

Nonproprietary Name

Taurolidine, Heparin

Labeler

ROVI Pharma Industrial Services SA

Dosage Form

SOLUTION

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit